Skip to main navigation
Skip to search
Skip to main content
Search All UT System Experts
University of Texas Southwestern Medical Center Home
Home
Profiles
Research units
Equipment
Research output
Search by expertise, name or affiliation
PARP Inhibitors for Cancer Therapy
Ken Y. Lin,
W. Lee Kraus
Obstetrics & Gynecology - Chairman's Office
Obstetrics & Gynecology
Pharmacology
Research output
:
Contribution to journal
›
Short survey
›
peer-review
77
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'PARP Inhibitors for Cancer Therapy'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
rucaparib
88%
Poly(ADP-ribose) Polymerase Inhibitors
64%
olaparib
37%
Germ-Line Mutation
27%
Mutation
27%
DNA Replication
24%
DNA Repair
22%
Ovarian Neoplasms
22%
Neoplasms
15%
Pharmaceutical Preparations
10%
Therapeutics
8%
Chemical Compounds
Rucaparib
100%
Olaparib
45%
Mutation
41%
Poly(ADPribose)
33%
Drug
12%